Monte Rosa Therapeutics, Inc.

GLUE

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001826457

SEC filings (opens in a new tab)

In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.

Q2 2026 vs. Q1 2026

How the institutions holding Monte Rosa Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of GLUE: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	191	3	192	+4
Shares	87.0M	715.6K	92.7M	+6.43M (+7.5%)
Value	$1.43B	$11.8M	$2.24B	+$823.4M (+58.0%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to GLUE in Q2 2026
Institution	Shares	Value	% of portfolio
Jupiter Topco LLC	1,072,494	$26.0M	0.01%
Opaleye Management Inc.	745,000	$18.0M	1.63%
First Trust Advisors LP	647,796	$15.7M	0.01%
Boone Capital Management LLC	615,287	$14.9M	3.48%
Duquesne Family Office LLCSuperinvestorDuquesne Family Office	297,600	$7.20M	0.17%
Longaeva Partners L.P.	216,792	$5.25M	0.15%
StemPoint Capital LP	153,544	$3.72M	0.64%
ExodusPoint Capital Management, LP	121,121	$2.93M	0.03%
Caption Management, LLC	112,322	$2.72M	0.10%
Jain Global LLC	110,647	$2.68M	0.03%
Polygon Management Ltd.	56,052	$1.36M	0.22%
Y-Intercept (Hong Kong) Ltd	25,149	$608.6K	0.01%
Verition Fund Management LLC	20,500	$496.1K	0.00%
HighTower Advisors, LLC	15,311	$370.5K	0.00%
Fox Run Management, L.L.C.	14,883	$360.2K	0.06%
Himension Fund	14,661	$354.8K	0.02%
Arizona State Retirement System	13,247	$320.6K	0.00%
Virginia Retirement Systems Et Al	11,300	$273.5K	0.00%
Pallas Capital Advisors LLC	9,138	$221.1K	0.01%
Pacer Advisors, Inc.	981	$24.0K	0.00%
Kemnay Advisory Services Inc.	715	$17.3K	0.00%
Silver Grove Financial Group, Inc.	116	$2.81K	0.00%
Quarry LP	67	$1.62K	0.00%
Caitong International Asset Management Co., Ltd	40	$968	0.00%
Valued Wealth Advisors LLC	39	$944	0.00%
Ameritas Advisory Services, LLC	23	$557	0.00%
National Bank of Canada	11	$266	0.00%

Sold out (23)

Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of GLUE in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Arrowstreet Capital, Limited Partnership	647,739	$10.7M
Cormorant Asset Management, LP	400,000	$6.58M
Millennium Management LLC	191,382	$3.15M
OpenArc Corporate Advisory, LLC	100,227	$1.65M
Acadian Asset Management LLC	78,513	$1.29M
Hussman Strategic Advisors, Inc.	63,000	$1.04M
Prelude Capital Management, LLC	43,473	$715.1K
Allstate Corp	27,956	$459.9K
Jefferies Financial Group Inc.	27,506	$452.5K
Omers Administration Corp	27,100	$445.8K
Rangeley Capital, LLC	27,016	$444.4K
Man Group plc	25,262	$415.6K
Mariner, LLC	17,117	$281.5K
Simplex Trading, LLC	14,710	$242.0K
LPL Financial LLC	14,450	$237.7K
DRW Securities, LLC	14,296	$235.2K
Winton Group Ltd	12,482	$205.3K
Martingale Asset Management L P	12,424	$204.4K
Colony Group, LLC	11,612	$191.0K
Federated Hermes, Inc.	1,628	$26.8K
MAI Capital Management	227	$3.73K
Massmutual Trust Co FSB	103	$1.69K
JPL Wealth Management, LLC	8	$132

Not filed for Q2 2026 yet (3)

Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GLUE in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Janus Henderson Group PLC	685,926	$11.3M
CWM, LLC	29,687	$488.4K
Sunbelt Securities, Inc.	1	$16